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Abstract
Purpose of Review The aim of the study is to perform a crit-
ical assessment of in vitro models of pre-eclampsia using
complementary human and cell line-based studies.
Molecular mechanisms involved in spiral uterine artery
(SUA) remodelling and trophoblast functionality will also be
discussed.
Recent Findings A number of proteins and microRNAs have
been implicated as key in SUA remodelling, which could be
explored as early biomarkers or therapeutic targets for preven-
tion of pre-eclampsia.
Summary Various 2D and 3D in vitro models involving tro-
phoblast cells, endothelial cells, immune cells and placental
tissue were discussed to elucidate the pathogenesis of pre-
eclampsia. Nevertheless, pre-eclampsia is a multifactorial dis-
ease, and the mechanisms involved in its pathogenesis are
complex and still largely unknown. Further studies are re-
quired to provide better understanding of the key processes
leading to inappropriate placental development which is the
root cause of pre-eclampsia. This new knowledge could iden-
tify novel biomarkers and treatment strategies.
Keywords Pre-eclampsia . Preeclampsia . Pregnancy .
Trophoblast cells . Endothelial cells . Spiral uterine artery
remodelling . In vitro models . Angiogenesis
Introduction
Pre-eclampsia occurs in pregnancy, and it is characterised by
new onset of hypertension with proteinuria or other organ
dysfunctions after 20-week gestation [1]. Pre-eclampsia is
the leading cause of maternal and foetal morbidity and mor-
tality worldwide [2]. Pre-eclampsia occurs in 4–6% of preg-
nancies [2]. Certain pre-existing conditions such as type 1 and
type 2 diabetes mellitus (DM) can increase the risk of pre-
eclampsia up to 4-fold [3, 4].
Pre-eclampsia does not only have short-term risks, but long
term can lead to cardiovascular disease and/or type 2 DM in
both mothers and their offspring [5, 6]. Currently, there are no
reliable and early predicative biomarkers, preventative mea-
sures or treatment strategies, other than delivery. The mecha-
nistic data related to the development of pre-eclampsia is lack-
ing, and, as a result, the pathogenesis of pre-eclampsia is
poorly understood. Some of the processes which appear to
be involved in the development of pre-eclampsia include in-
appropriate remodelling of spiral uterine artery (SUA) likely
caused by inadequate function of trophoblast cells [7].
Inadequate remodelling of SUA leads to restricted supply of
oxygen and nutrients to placenta and, therefore, placental hyp-
oxia [8].
Spiral Uterine Artery Remodelling by Trophoblast Cells:
Physiological Processes
In the early stages of embryogenesis (5 days after
fertilisation), the mammalian blastula is referred to as a blas-
tocyst, a hollow bundle of cells that has undergone minor cell
differentiation. The outermost layer of the blastocyst is called
the trophectoderm, which comprises of trophoblast cells. The
blastocyst, following various morphogenetic events, un-
dergoes implantation in the decidua, a membrane lining the
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uterus. Subsequently, trophoblast cells from the blastocyst
start to migrate towards the SUA, and remodelling process
begins [9]. Chorionic villi sprouting from the blastocyst are
involved in invading the endometrium of the mother. This
placental villous growth occurs under hypoxic conditions,
aiding the proliferation of certain trophoblast cell types [10,
11]. The established oxygen gradient during placental devel-
opment determines the action of the trophoblast cells, whether
they migrate or proliferate [12]; this is because a change from
low to high placental oxygen causes trophoblasts to develop
an invasive nature, instead of proliferating [13]. Once dilation
of SUA occurs by invasive trophoblasts, the change is irre-
versible, ensuring a constant blood flow to the developing
foetus [14]. However, placental hypoxia beyond the first tri-
mester is associated with pregnancy pathologies such as pre-
eclampsia [15].
The multifaceted progression of blastocyst implantation into
the decidua is governed by an array of timed mechanisms and a
variety of key molecules. Human chorionic gonadotrophin
(hCG) is highly expressed by the blastocyst prior to implantation
[16], and hyperglycosylated hCG (hCG-H) is continually pro-
duced by the syncytiotrophoblasts subsequent to implantation
[17] which, then, leads to invasion of trophoblasts [18].
Cytotrophoblasts are constantly undergoing differentiation into
syncytiotrophoblasts in the floating villus to enable expansion.
However, these cells also give rise to the extravillous trophoblast
cells (EVTs). In relation to the villous stroma, proximal
cytotrophoblast cells are differentiating, whereas distal
cytotrophoblast cells are deemed column cytotrophoblasts that
no longer proliferate. Hypoxic conditions have been shown to
prevent the differentiation of cytotrophoblasts in vitro [10]. The
differentiated syncytiotrophoblasts, which form a continuous and
multinucleated syncytium, line the outer layer of the villi, where-
as the undifferentiated cytotrophoblasts form the inner layer and
give rise to a variety of different trophoblast cells, such as
syncytiotrophoblasts [13] or column cytotrophoblasts [19].
Syncytiotrophoblasts are in direct contact with maternal
blood and thus provide the biochemical barrier between the
mother and developing foetus. Within the anchoring villous
tips, cytotrophoblasts differentiate into EVTs, which emerge
from the cell column and migrate through the maternal decid-
ua with the intention of remodelling the SUA [20, 21].
Endovascular trophoblasts, as their name suggests, enter
through the distal lumen of the SUA, whereas interstitial tro-
phoblasts enter via the decidua [22] where they begin the
process of remodelling (Fig. 1). Arrival of endovascular tro-
phoblasts leads to the removal of maternal endothelial cells
[23]. Invasion of the SUA results in the loss of endothelial
lining and elastic tissue. The increase in width of these vessels
is partly due to the loss of elasticity, which, in turn, provides a
lower resistance vessel enabling blood supply to the develop-
ing foetus. Invading trophoblast cells in the SUA replace the
original maternal endothelial cells [22].
Despite substantial knowledge in relation to the physiolog-
ical processes involved in SUA remodelling by trophoblasts,
aberrant mechanisms impeding these processes are not well
established. Therefore, there is an urgent need for effective
experimental models which will help elucidate many of the
unknown aspects of inappropriate SUA remodelling leading
to pre-eclampsia and aid the development of effective preven-
tive and therapeutic strategies. In this review, we will critically
assess existing complementary human and cell line-based
in vitro models used to elucidate various mechanisms in-
volved in SUA remodelling, which could be relevant to the
pathogenesis of pre-eclampsia.
Two-Dimensional Cell Migration and Invasion Assays
The invasion assay is a high-throughput method which as-
sesses cellular motility through a permeable membrane there-
fore representing trophoblast migration through the
endometrium.
Within the Rho family of GTPases, Rac1 has been shown
to act as a regulator of many important cellular processes, such
as migration and invasion [24]. HTR-8/SV.neo trophoblast
cells were originally derived from chorionic villi explants
and were transfected with the simian virus 40 large T antigen
[25]. Fan and colleagues used short hairpin (sh) RNA to si-
lence Rac1 expression in HTR-8/SV.neo cells before
performing a transwell Matrigel invasion assay. Following
the knockdown of Rac1, HTR-8/SV.neo cells were allowed
to grow for an additional 24 h in transwell inserts, before the
invading cells were fixed in paraformaldehyde and stained
with crystal violet. By counting cells in ten random fields of
view, it was shown that Rac1 knockdown significantly re-
duced migration of HTR-8/SV.neo cells in comparison to the
control [26].
Other important regulators of cell migration, elastin-
derived peptides (EDPs) have been implicated in the conver-
sion of the SUA into a low resistance vessel [27]. Using this
knowledge, Desforges et al. modelled functional aspects of
SUA by exposing trophoblast cells, SGHPL-4, to an elastin-
derived matrikine, VGVAPG. SGHPL-4 cells are EVTs de-
rived from the first trimester of pregnancy. The invasion of
SGHPL-4 cells through a transwell plate was increased when
exposed to VGVAPG for 24 h [28].
MicroRNAs are small non-coding RNA molecules that
regulate gene expression, through silencing or post-transcrip-
tional regulation therefore affecting stability and translation of
messenger RNA (mRNA). Tamaru et al. demonstrated that
overexpression of miR-135b significantly reduced the inva-
sive capacity of HTR-8/SV.neo cells, by causing a decrease in
the mRNA expression of CXCL12 by approximately 50%, in
low-oxygen conditions [29]. TheCXCL12 gene plays a role in
placentation [30] and is linked to the development of pre-
eclampsia [31], whereas miR-135b is expressed in trophoblast
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cells [29]. The functional role of miR-93 has yet to be eluci-
dated in pre-eclampsia; however, the levels of this microRNA
are increased within the plasma of patients who developed
pre-eclampsia. SOLiD sequencing revealed a total of 20
downregulated microRNAs in plasma samples obtained from
five patients, of which four had developed pre-eclampsia
[32•]. Furthermore, Pan et al. have shown that miR-93 inhib-
itors can stimulate trophoblast migration and invasion [33].
Choriocarcinoma is a rapidly growing cancer of the placenta,
in particular the chorion. Placental choriocarcinoma-derived
cell lines, BeWo and JAR cells, in a transwell chamber also
displayed reduced motility when transfected with miR-93 mi-
metics [33].
As men t ioned above , hCG-H is sec r e t ed by
syncytiotrophoblasts during early placentation [34]; however,
it is also secreted by choriocarcinoma cells. Using xCelligence
(ACEA, San Diego) real-time cell analysis system, Evans
et al. performed migration and invasion assays using JEG-3
cells. Cell invasion was inhibited following a reduction of
hCG-H by hCG-H neutralising antibody, whereas there was
no effect on cell migration [18].
Metastasis-associated protein-3 (MTA-3) can also regulate
cell migration. In pre-eclampsia, the levels of MTA-3 appear
to be reduced [35]. Therefore, when Horii et al. generated
MTA-3 stable knockdown in choriocarcinoma JEG-3 cells
using shRNA, there was a 60% decrease in hCG secretion in
the knockdown models compared to control, and migration
was increased by 1.8-fold [36].
Moreover, Liu and colleagues have implicated that ephrin-
B2 could play an important role in the remodelling of SUA
due to its influence on trophoblast cell functionality [37••].
Ephrin-B2 is a transmembrane ligand of Eph receptors, and
Fig. 1 Schematic diagram of spiral uterine artery remodelling by
trophoblasts and in vitro assays used to model different stages in this
process. Chorionic villi sprouting from the blastocyst consist of two
distinct villous trophoblast cell types: syncytiotrophoblasts and
cytotrophoblasts. The syncytiotrophoblasts forms the outer layer of the
chorionic villi, whereas cytotrophoblast layer is considered stem like.
Column trophoblasts are found in the anchoring villi where they form
partially complete shell facilitatingmovement of extravillous trophoblasts
through the maternal decidua (migration). Interstitial trophoblasts, upon
entering decidua, gather and destroy arterial media (invasion); endothelial
cells undergo apoptosis, which allows for their replacement by
endovascular trophoblasts (co-culture). The most commonly found
lymphocytes in the decidua during pregnancy are natural killer (NK)
cells (co-culture)
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it belongs to the largest family of receptor tyrosine kinases
[38]. It regulates embryonic vascular development and post-
natal angiogenesis [39]. Ephrin-B2 and its role in SUA remod-
elling were analysed using a number of functional assays with
HTR-8/SV.neo cells. The migration, invasion and tube forma-
tion of HTR-8/SV.neo cells were diminished when ephrin-B2
was knocked down using sh-ephrin-B2. The expression of
MMP-2 and MMP-9, key proteins involved in the breakdown
of the extracellular matrix and remodelling, was also de-
creased in the transfected cells [40].
The Notch pathway, a regulator of ephrin-B2 expression
[37••], is one of the key angiogenic and stem cell pathways
[41]. It is a canonical pathwaywhere ligands such as delta-like
(DLL) 1, 3 and 4 on one cell activate notch receptors (1–4) on
the neighbouring cells. Inhibition of DLL4 has been shown to
promote endothelial cell proliferation, but it leads to irregular
pro-angiogenic phenotype, and therefore, it is likely to be
implicated in endothelial dysfunction [42]. Protein or RNA
expressions of DLL4 and other members of the Notch path-
ways such as Notch-2, Notch-3, DLL3, JAG1, JAG2, Hey-1
and Hey-2 were all downregulated in cell lysates from placen-
tal samples collected from women with pre-eclampsia com-
pared to healthy control placentae [43]. The shRNA downreg-
ulation of Notch-2 receptor led to a decrease in BeWo cell
migration and invasion, whereas overexpression of Notch-2
led to an increase in the migration and invasion of JAR cells
[44]. Conversely to Notch, other stem cell markers, CD44 and
CD34, have shown higher expression in placental samples
collected fromwomen with pre-eclampsia (n = 21) vs. normo-
tensive controls (n = 20) [45].
Endothelial progenitor cells (EPCs) are essential in vascular
remodelling and endothelial homeostasis [46]. EPCs are able to
form new blood vessels, and therefore have a key role in vas-
cular repair [47]. Blood samples from 13 women with pre-
eclampsia demonstrated a lower number of EPCs compared to
healthy controls. A reduction in EPC number was demonstrated
before pre-eclampsia developed clinically [48]. Similarly, a re-
duced number of endothelial colony-forming cells (ECFCs),
which are a subclass of EPCs committed to become endothelial
cells [49], was also observed within umbilical cord blood from
women with pre-eclampsia [50••], suggesting that the reduction
in EPCs is present both prior and after pre-eclampsia develops.
The reduction and dysfunction of EPCs reflects the lack of
endothelial repair capacity in pre-eclampsia [51]. Liu and col-
leagues isolated and cultured EPCs from umbilical cord blood
and placentae from 12 women with pre-eclampsia and 12
healthy pregnant women at delivery [37••]. Western blotting
and RT-PCR results using isolated EPCs demonstrated higher
ephrin-B2 mRNA and protein levels in women with pre-
eclampsia. This was also true within placental samples.
Furthermore, the number of EPCs isolated from umbilical cord
were negatively correlated with the expression of ephrin-B2
levels in placentae. A small molecule-based activation of
DLL4 and Notch pathway led to activation of ephrin-B2 in
EPCs and inhibition of EPC activity [37••]. In conclusion,
Notch or ephrin-B2 could be potential targets capable of
repairing angiogenesis in patients with pre-eclampsia [37••].
Two-dimensional cell culture assays, such as the migration
or invasion assay, provide a useful tool to study the function-
ality of trophoblast cells. Despite their importance, it is neces-
sary to conduct further three-dimensional assays to better
mimic human environment.
Three-Dimensional Cell Culture-Based Models
Time-lapse microscopy, three-dimensional (3D) invasion and
tube formation assays were all used by Wallace et al. to assess
trophoblast functionality in the presence of increasing concen-
trations of angiogenin or endostatin. Invasion and tube forma-
tion were reduced significantly in the presence of endostatin,
whereas angiogenin decreased invasion but increased tube for-
mation. Similarly, when fibrin gel assay was used to determine
the volume of invading trophoblast cells from a 3D spheroid
(stimulated by endothelial growth factor, and in the presence of
endostatin), the invasive ability of SGHPL-4 trophoblast cells
was decreased considerably. On the other hand, there was no
change in cell motility by endostatin or angiogenin [52•].
A 3D co-culture model of trophoblast cells and endometrial
adenocarcinoma cells demonstrated interesting results in rela-
tion to invasive capacity of trophoblasts in this system. Three
different endometrial adenocarcinoma cell lines were used to
emulate epithelial cells of the endometrium: the HEC-1-A cell
line, the RL95-2 cell line and the Ishikawa cell line.
Endometrial epithelial cells (EECs) were mixed with
Matrigel, and once solidified, medium containing the same cell
line was added to the chamber slide. Following 4-day incuba-
tion, the EECs formed spheroids; trophoblast cells (AC-1M88)
were, then, added to EEC spheroids. Trophoblast cells attached
to the EECs forming a cell monolayer. Out of three endometrial
cell lines, trophoblast cells were able to invade RL9-2 cells the
most effectively. Interestingly, the RL9-2 spheroids formed in
the Matrigel showed the least polarisation out of the three en-
dometrial cell lines. A higher extent of differentiation and
polarisation decreased trophoblast invasion [53••].
In co-culture experiments carried out by Virtanen and col-
leagues, human CRL-2522 fibroblasts and HUVEC displayed
a pro-angiogenic phenotype. Similarly, a co-culture of human
adipose stem cells (hASCs) and HUVEC demonstrated acti-
vation of angiogenesis and vasculogenesis. However, when
cord blood serum from women with pre-eclampsia was added
to these co-culture models, tubule formation was inhibited in
both models compared to when serum from normotensive
cord blood was added; this reflects the anti-angiogenic state
that is present in pre-eclampsia [54].
Women with gestational diabetes mellitus (GDM) have in-
creased risk of developing pre-eclampsia, up to 10% [55, 56].
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Therefore when feto-placental endothelial cells were cultured
with conditioned media derived from trophoblasts isolated
from patients with GDM, the cells migrated slower in a wound
scrape assay and showed reduced chemo-attraction/migration
through chamber pores [57]. Furthermore, when Loegl et al.
investigated feto-placental angiogenesis in women with
GDM, primary trophoblast-conditioned media from women
with GDM led to increased tube formation but reduced wound
healing and chemo-attraction ability [57]. GDM also altered
expression and secretion of pro-angiogenic and anti-
angiogenic factors therefore leading to changes in placental
angiogenesis and vascular structure, which is common in
GDM pregnancies [57]. Other nutrient-sensing pathways rel-
evant to DM, such as the AMPK pathway the main target of
metformin, have been implicated in trophoblast functionality
and endothelial function, and hence, it could be a relevant
target for prevention of pre-eclampsia [58–60].
Cell Survival and Proliferation
As previously explained, the cytotrophoblast cells undergo
proliferation during hypoxic conditions; survival and prolifer-
ation are essential for appropriate and efficient remodelling of
SUA. Following invasion of the SUA lumen, EVTs must sur-
vive long enough to carry out remodelling functions.
Pre-implantation factor (PIF) is a peptide secreted by em-
bryos, which has been implicated in trophoblast invasion of
SUA [61, 62]. Placentae collected from women with pre-
eclampsia demonstrated lower placental protein levels of PIF
compared to healthy controls [61]. Moindjie and colleagues
used a synthetic PIF analogue (sPIF) to elucidate its role in
early stage trophoblast apoptosis. Using an annexin V-FITC
staining assay by flow cytometry, the number of apoptotic
HTR-8/SV.neo cells was reduced in the presence of 50 or
100 nM sPIF by 26.3 and 39.6%, respectively [63].
Furthermore, in a late-stage apoptosis (DNA fragmentation)
assay, sPIF treatment showed a significantly lower apoptotic
index when assessed by a terminal deoxynucleotidyl
transferase-mediated dUTP-biotin DNA-nick end labelling
(TUNEL) assay [63].
In relation to ephrin-B and Notch signalling, in addition to
their role in migration and invasion, the knockdown of ephrin-
B2 showed a small reduction in cell proliferation, assessed by
the CCK-8 assay. Similarly, a higher number of apoptotic cells
was observed via Hoechst 33258 staining following a knock-
down of ephrin-B2 [40]. In relation to Notch receptors, pro-
liferation of JAR cells was decreased when Notch-2 was
overexpressed; however, the knockdown of Notch-3 led to
an increase in proliferation. Notch-2 knockdown increased
the volume of BeWo cells undergoing the S phase of the cell
cycle, effectively increasing proliferation [44].
Matricellular proteins of the CCN family also play a role in
trophoblast proliferation and migration [64]. Within this
family of proteins, CCN1 and CCN3 are known to affect cell
growth, as well as cell migration [65]. Following treatment
with recombinant CCN1 and CCN3 proliferation of
SGHPL-5 trophoblast cells was reduced and the cell cycle
progression arrested [65].
In summary, 3D cell culture models have an advantage over
2D models because these resemble the human environment
better, enabling assessment of direct and indirect cell-cell inter-
actions as well as interactions between the cells and the sur-
rounding environment. Overall, 3D models are more effective-
ly used with primary cells and tissue explants than with cell
lines. Summary of the molecular mechanisms identified using
2D and 3D in vitro models are presented in Table 1.
In Vitro Models with Placental Explants or Primary
Trophoblast Cells
The role of EDPs has already been discussed above in relation to
their stimulatory effect onmigration and invasion using cell lines.
Here, the effect of EDPs was also investigated using placental
explants. Following the removal of villous tips from the first
trimester placental tissue, extravillous trophoblast outgrowths
were derived and placed onto collagen. These explants were
allowed to adhere, before media containing the EDP mimetic,
VGVAPG, was added. Villi were imaged at several time points;
at each point, the area covered and the distance of growth trav-
elled were quantified. Outgrowth area and migration distance in
the presence of the EDP were shown to be significantly larger
than that of the control [28].
Key proteins involved in tissue remodelling, MMPs, par-
ticularly MMP-14 and MMP-15, appear to also play an im-
portant role in SUA remodelling [66, 67].When first-trimester
chorionic villi were cultured in the presence of endothelin-1, a
potent vasoconstrictor upregulated in pre-eclampsia [68], tro-
phoblast outgrowth was decreased by 24% [67]. Invasion was
also reduced by 26% following treatment with 100 nM of
endothelin-1. The mechanism implicated in the inhibitory ef-
fect of endothelin-1 was linked to downregulation ofMMP-14
and MMP-15 [67].
Mapsin is an epithelial-specific class II tumour suppressor
gene, which has been shown to have inhibitory actions on the
invasion of breast cancer cells. In addition to this, mapsin’s role
in placental development and invasion of cytotrophoblasts has
also been demonstrated [69]. In Liu et al., placental tissues were
collected after delivery from 12 women with pre-eclampsia and
12 healthy controls. Western blotting, RT-PCR and immunohis-
tochemistry (IHC) were conducted to assess mapsin expression
in placentae from women with pre-eclampsia and matched
group of healthy controls. The degree of methylation in the
promoter regions of mapsin in each of the study groups was
assessed. The patients were matched in terms of age, body mass
index (BMI), gestational age and parity. They found mapsin
mRNA and protein levels to be significantly higher in pre-
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Table 1 Summary table of the molecular mechanisms implicated in trophoblast or placental functionality
Cell or tissue type Stimulus Effect Ref.
HTR-8/SV.neo Rac1 shRNA Reduced migration
Snail expression was considerably reduced
[26]
SGHPL-4 cells Elastin-derived matrikine, VGVAPG Increased invasion [28]
HTR-8/SV.neo cells Overexpression of miR-135b Reduced invasion
CXCL12 mRNA expression downregulated
[29]
Patient plasma
(pre-eclampsia vs. healthy)
SOLiD sequencing Twenty microRNAs downregulated [32•]
BeWo and JAR cells miR-93 inhibitors Reduced invasion [33]
Feto-placental endothelial cells
derived from the third trimester
Conditioned media derived from
trophoblasts isolated from patients
with gestational diabetes mellitus
(GDM)
Reduced migration
Increased tube formation
[57]
JEG-3 cells hCG-H neutralising antibody reduced invasion,
no effect on migration
[18]
JEG-3 cells shRNA MTA-3 stable knockdown hCG secretion reduced
Migration increased
[36]
HTR-8/SV.neo cells Ephrin-B2 knocked down using
sh-ephrin-B2
Migration, invasion and tube formation
diminished
MMP-2 and MMP-9 expression decreased
Cell proliferation reduction
[40]
Cell lysates, from placental samples
(pre-eclampsia vs. healthy)
Protein and RNA isolation DLL3/DLL4/Notch-2/Notch-3/JAG-1/JAG-2/
Hey-1/Hey-2 downregulated
[43]
BeWo shRNA downregulation of
Notch-2 receptor
Reduced migration and invasion
Increased proliferation
[44]
JAR Overexpression of Notch-2 Increased migration and invasion
Decreased proliferation
[44]
JAR Knockdown of Notch-3 Increased proliferation [44]
Placental samples
(pre-eclampsia vs. healthy)
ELISA/flow cytometry Higher expression of CD44 and CD34 [45]
Blood samples
(pre-eclampsia vs. healthy)
Isolation of EPCs from peripheral
blood
EPCs considerably lower [48]
Cord blood
(pre-eclampsia vs. healthy)
Isolation of ECFCs Reduced number of ECFCs [50••]
EPCs from umbilical cord blood
and placentae
(pre-eclampsia vs. healthy)
Western blotting and RT-PCR Higher ephrin-B2 mRNA/protein levels
EPCs negatively correlated with the expression
of ephrin-B2
[37••]
SGHPL-4 Angiogenin or endostatin Reduced invasion and tube formation
with endostatin
Decreased invasion and increased tube
formation with angiogenin
No change in cell motility
[52•]
AC-1 M88 cells 3D co-culture model A higher extent of differentiation and polarisation
decreased trophoblast invasion
Trophoblast cells were able to invade RL9-2 cells
the most effectively
[53••]
Maternal and umbilical cord blood
samples
Cord blood serum CRL-2522 fibroblasts and HUVEC co-cultured,
displayed a pro-angiogenic effect
hASC and HUVEC co-cultured,
promoted angiogenesis/vasculogenesis
Cord blood serum from women with pre-eclampsia,
reduced tubule formation
[54]
Primary trophoblasts
(pre-eclampsia vs. healthy)
Plasma pre-implantation factor (PIF) Increased invasion [61]
HTR-8/SV.neo Synthetic PIF analogue (sPIF) Apoptosis reduced [63]
SGHPL-5 Recombinant CCN1 and CCN3 Proliferation reduced
Cell cycle progression arrested
[65]
Placental explants EDP mimetic, VGVAPG Outgrowth area and migration distance
significantly larger
[28]
First trimester chorionic villi Endothelin-1 Trophoblast outgrowth was decreased
Reduced invasion
[67]
Western blotting/RT-PCR/IHC Mapsin mRNA/protein levels higher [70]
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eclampsia group compared to healthy controls. IHC of placental
tissue showed an increased and more diffused staining of
mapsin in pre-eclampsia [70].
Moreover, calcyclin or S100A6 protein, a Ca2+channel-
binding protein which belongs to the S100 family of proteins,
is upregulated with the cellular stress response [71]. It is dif-
ferentially expressed in trophoblast cells isolated from preg-
nancies complicated by pre-eclampsia compared to healthy
controls [72]. Schol et al. investigated biomarker potential of
calcyclin in formalin-fixed and paraffin-embedded placental
tissue collected from 75 women with pre-eclampsia and the
same number of healthy controls who delivered between 20
and 34 weeks of gestation. IHC analysis showed a significant-
ly more intense staining of calcyclin in the trophoblasts from
women with pre-eclampsia compared to healthy controls [73].
Determining expression of trophoblasts’ calcyclin early in
pregnancy could be useful to investigate its role in the patho-
genesis of pre-eclampsia. However, obtaining placental sam-
ples early in pregnancy through chorionic villus sampling is
associated with a high incidence of miscarriage; if calcyclin’s
role in the pathogenesis of pre-eclampsia is to be further val-
idated, the most convenient method to measure its levels early
in pregnancy would be by using peripheral blood or urine
sample. Whether these samples correspond to the placental
levels needs to be investigated further.
Other important proteins and potential markers of pre-
eclampsia identified by IHC of the placental tissues are includ-
ed in Table 2 [61, 70, 74••, 75–87].
In addition to trophoblasts, other groups of cells, which are
important for appropriate SUA remodelling and placental de-
velopment, include immune cells.
In Vitro Immune Cell-Based Models
Adequate signalling between foetal and maternal immune
cells is an essential requisite to achieve adequate and early
pregnancy placentation, vasculogenesis and immune
tolerance of the foetus [88]. Natural killer (NK) cells are
a major source of angiogenic growth factors and cyto-
kines that ensure the transformation of the SUA, foetal
implantation and placentation [89–91]. Abnormal NK cell
receptors and cytokine production profile are associated
with pregnancy disorders, such as pre-eclampsia [92].
Interferon-gamma secretion by NK cells is an essential
regulator of vascular remodelling and EVT migration.
Lowered levels of interferon-gamma were observed in de-
cidual NK (dNK) cells from pregnant women with hyper-
tensive disorders [93].
Major histocompatibility complex class I-related
chain (MIC) genes are stress-inducible proteins modulat-
ing the function of immune NK cells. Engagement of
NKG2D receptor by MIC genes has been shown to
stimulate NK cell-mediated cytokine production, and
the release of soluble MIC proteins was also suggested
to modulate NK cell function during pregnancy [94,
95].
Sphingosine-1-phosphate (S1P) has been shown to regu-
late numerous functions of NK cells therefore having a poten-
tial role in SUA remodelling. Therefore, when Zhang et al.
cultured HTR-8/SV.neo cells overnight in serum-free media,
before wounding a confluent monolayer of cells and adding
leukocytes pre-treated with FTY720, an S1P analogue, the
migration was considerably reduced [96]. The extent of mi-
gration was analysed by photographing 10 randomly chosen
areas of the wound scrape. This way of assessing migration
could lead to inconsistencies due to moderate variations in the
wounding process. Wound sizes can be variable, and, as a
result, this only provides a rough basis for migration with
reduced reproducibility. The use of culture inserts with a de-
fined free cell gap can provide a standardised wound size,
avoiding any cell damage. Using live cell microscopy imaging
with a Mark & Find/Tile Scan feature allows for identical
sections of a well to be imaged, with the use of pre-defined
co-ordinates.
Table 1 (continued)
Cell or tissue type Stimulus Effect Ref.
Placental tissues
(pre-eclampsia vs. healthy)
IHC IHC: increased and more diffused
staining of mapsin
Placental tissue
(pre-eclampsia vs. healthy)
IHC IHC: more intense staining of calcyclin
in the trophoblasts isolated from patients with
pre-eclampsia
[73]
HTR-8/SV.neo Leukocytes pre-treated with FTY720,
an S1P analogue
Reduced migration [96]
HUVEC NK cells treated with FTY720, an
S1P analogue
Reduced HUVEC tubule formation [96]
Placental CD74-positive macrophages CD74 was silenced by siRNA Reduced ability to adhere to trophoblast cells [98]
SGHEC-7 dNK-conditioned media
(impaired SUA remodelling vs.
healthy)
Reduced endothelial cell destabilisation [103••]
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Table 2 Important cell markers within placental tissue and their relevance in pre-eclampsia
Protein Target cells Relevance Origin of placenta
(trimester)
Ref.
I II III
α-Smooth muscle actin Vascular smooth muscle cells
of SUA
SUA remodelling + [74••]
Decidual mesenchymal stem
cells (DMSCs)
+
Angiogenin Syncytiotrophoblasts
Cytotrophoblasts
Important for placental vasculogenesis
and organogenesis
+ [75]
CRIPTO-1 EVT Increased in creta placentae + [76]
Cytokeratins AE1/AE3 CVTs
EVTs
Epithelial differentiation and pan-trophoblast
marker
+ + [61]
CK5 CVTs
EVTs
Epithelial differentiation marker + [77, 78]
CK7/CK18/CK19 CVTs
EVTs
Epithelial differentiation marker
Decreased significantly in pre-eclampsia
+ [77-79]
CK8 CVTs
EVTs
Amniotic epithelium
Epithelial differentiation marker
Decreased significantly in pre-eclampsia
+ [77, 78]
CK14 BeWo cells
Primary trophoblast cells
Amniotic epithelium
Epithelial differentiation marker
Trophoblast progenitor cells markers
+ [77, 79]
CK20 CVTs
EVTs
Marker of molar pregnancy + [77]
E-Cadherin Syncytiotrophoblasts Epithelial differentiation marker
Increased in pre-eclampsia
+ [77, 79]
EGF receptor splice variant
(p110/EGFR)
Syncytiotrophoblasts EGF receptor antagonist
Increased in pre-eclampsia
+ [80]
Epidermal growth factor (EGF) Villous cytotrophoblasts Decreased in pre-eclampsia +
Endoglin (Eng) or CD105 Syncytiotrophoblasts
Endothelial cells
Increased in pre-eclampsia + [81]
Galectin-2 Syncytiotrophoblasts Decreased in pre-eclampsia + [82]
HIF-1α Syncytiotrophoblasts Increased in pre-eclampsia + [83]
HLA-G CVTs
EVTs
Identification of cytotrophoblasts and EVTs + + [61]
Maspine CVT
Endothelial cells
Increased and more diffused expression in
pre-eclampsia
+ [70]
Matrix metalloproteinase type 9 Decidual cells Increased in pre-eclampsia + [84]
Matrix metalloproteinase types 1 and 3 Decidual cells
Interstitial EVTs
Important for trophoblast invasion and
remodelling of SUA
Increased in pre-eclampsia
+ [84]
Placental growth factor (PlGF) Syncytiotrophoblasts Decreased in pre-eclampsia + [83]
Pre-implantation factor (PIF) EVT
CVT
Important for trophoblast invasion and
placentation
+ + [61]
pSTAT3 Endothelial cells of SUA Increased in pre-eclampsia + [85]
Pyruvate kinase M2 (PKM2) Syncytiotrophoblasts Increased expression in pre-eclampsia + [86]
VEGF R1 Trophoblasts
Immune cells
Increased expression in pre-eclampsia
(83)/no change (85)
+ [85, 87]
R2 Endothelial cells No change in pre-eclampsia + [85]
R3 Trophoblasts
Endothelial cells
Expression decreased in endothelial cells
in pre-eclampsia
+ [85]
Vimentin Stromal mesenchymal cells
of chorionic villi
Cell identification + [77]
SUA, spiral uterine artery; PMC, placental mesenchymal cells; CVT, chorionic villous trophoblasts; EVT, extravillous trophoblasts; dNK, decidual
natural killer
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When primary trophoblast cells from villous tips were
added to Matrigel-coated inserts, in the presence of NK cells
pre-treated with FTY720, a reduction in trophoblast migration
was observed. When NK cells pre-treated with FTY720 were
cultured with HUVEC, inhibition of tubule formation was
also observed. These results stipulate an important role of
NK cells and S1P in the process of SUA remodelling and
developmental angiogenesis [96].
In the study by Haumonte et al., peripheral blood was col-
lected from a cohort of 81 pregnant women diagnosed with
vascular pregnancy diseases including 40 women with pre-
eclampsia and 63 healthy pregnancies matched for age, BMI
and parity. Plasma levels of solubleMIC (sMIC), NKG2D and
interferon-gamma were measured using ELISA, flow cytom-
etry and RT-PCR. Plasma samples, which were positive for
sMIC, demonstrated higher incidence of pre-eclampsia and
proteinuria and lower levels of NKG2D and interferon-gam-
ma. Therefore, the presence of sMIC molecules in maternal
plasma may play a critical role in altering maternal immune
functions which is essential for appropriate vascular remodel-
ling during pregnancy [97].
Furthermore, placental growth is facilitated by the inter-
action between trophoblast and immune cells [98]. The im-
portance of the immune system is further confirmed by the
fact that inflammatory markers are raised in pre-eclampsia
[99]. Hofbauer cells are placental macrophages of foetal
origin and play a direct role in early placental development
[98]. These cells are associated with several pregnancy
complications, such as chorioamnionitis, spontaneous
abortion and foetal metabolic storage disease. They con-
tribute to the placental expression of anti-angiogenic fac-
tors, and they appeared to be aberrant in placentae from
women with pre-eclampsia [100]. The human leukocyte
antigen class II histocompatibility antigen-gamma chain,
also known as cluster of differentiation 74 (CD74), when
expressed on cell surfaces, is the major histocompatibility
complex (MHC) II invariant chain protein that is involved
in antigen presentation and crucial for biogenesis [101].
CD74 has also a high affinity binding protein for the pleio-
tropic inflammatory cytokine macrophage migration inhib-
itory factor (MIF). Przbyl et al. hypothesised that CD74 has
an important role in aberrant placentation in pre-eclampsia.
Indeed, the number of CD74-positive macrophages was
significantly lower in placental samples collected from
women with pre-eclampsia (n = 50) compared to healthy
controls (n = 28) [98]. When CD74 was silenced by siRNA,
macrophages displayed a reduced ability to adhere to tro-
phoblast cells in comparison to the control. The Ingenuity
Pathway Analysis Tool determined that the gene expression
levels of activated leukocyte cell adhesion molecule
(ALCAM), intracellular adhesion molecule 4 (ICAM4)
and Syndecan-2 (SDC-2), known to be involved in cell
adhesion, were considerably reduced [98].
Within the decidua during early pregnancy, NK cell popu-
lation is abundant, making up 50–90% of the total lymphocyte
count [102]. Although dNK cells are present during SUA
remodelling, their function has not yet been fully elucidated
in relation to endothelial remodelling and integrity. Fraser
et al. attempted to address this question by isolating dNK cells
at 9–14 weeks of gestation from healthy pregnancies and
pregnancies that showed abnormal uterine artery Doppler re-
sults as per resistance indices. The decidua was processed, and
CD56+ cells were sorted and cultured as dNK cells for 24 h
before conditioned growth media was removed and pooled
together. SV40 transfected human umbilical vein endothelial
cells (SGHEC-7) were plated in Angiogenesis ibiTreat cham-
ber slides containing Matrigel and allowed to form tube-like
structures. Standard culture media were then replaced with
dNK-conditioned media. Prior to invasion of SUA by tropho-
blasts, the SUA must undergo various physiological changes
in their structure including forming gaps in the endothelial
layer to promote invasion (Fig. 1). SGHEC-7 cells cultured
with dNK-conditioned media from pregnancies with abnor-
mal Doppler results did not show endothelial cell
destabilisation to the same extent as those cultured in dNK-
conditionedmedia from healthy pregnancies. This implies that
dNK have a role in disrupting endothelial structure and that a
reduction in this disruption may be a contributing factor to the
inadequate SUA remodelling. The likely mechanism of this
effect is not apoptotic but rather pro-inflammatory involving
TNF-α signalling [103••].
Similar to Fraser et al., another group isolated dNK cells
from healthy pregnancies and pregnancies with abnormal
uterine artery Doppler or high-resistance index, with an aim
of profiling cytokines and angiogenic factors secreted in the
culture media of dNK cells. Both angiogenin and endostatin
were produced at a higher level by dNK cells from pregnan-
cies with high resistance index. Endostatin inhibited tropho-
blast invasion and endothelial-like trophoblast tube formation,
while angiogenin inhibited trophoblast invasion but promoted
tube formation. In summary, altered expression of angiogenin
and endostatin which are secreted by dNK cells may contrib-
ute to pregnancy complication associated with SUA remodel-
ling [52•].
Conclusion
The current available in vitro systems used to model pre-
eclampsia have so far helped to elucidate numerous key pro-
teins potentially involved in the development of this condition
(Tables 1 and 2). However, there are still many aspects of the
pathogenesis of pre-eclampsia that remain unknown.
Although cell culture models remain essential to study the
mechanisms of diseases, pre-eclampsia is a complex and mul-
tifactorial disease of unknown aetiology, and, as such, it is
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important to appreciate the limitations of these models.
Selecting appropriate assays to elucidate key features of the
pathophysiology of pre-eclampsia is necessary to ensure the
generation of robust results. Currently, there is notable varia-
tion between experimental designs of the same assays, so per-
haps standardisation of the methodology may attempt to ad-
dress this, leading to greater reproducibility. Co-culture and
3D in vitro models, particularly with primary cells, help to
mimic a more realistic cellular environment and provide pre-
liminary data important for the development of future or
repurposed therapies. Nevertheless, propagation of cells and
manipulation of expression of various key proteins are only
possible with cell lines. Furthermore, in vivo animal models
have the advantage of pre-clinical testing of a therapeutic;
however, initial in vitro work generally precedes in vivo ex-
perimental phase. Even though ex vivo assays only partly
emulate an in vivo setting, they allow us to underpin key
molecules or pathways in a disease.
In summary, despite a substantial progress which has been
made in the field of pre-eclampsia and in relation to under-
standing the function and key signalling mechanisms of tro-
phoblast cells and SUA remodelling, further studies are re-
quired to fully elucidate the mechanisms involved in the path-
ogenesis of pre-eclampsia. Identification of the key pathways
involved in placental dysfunction, which is the root cause of
pre-eclampsia, can lead to the development of reliable and
early biomarkers of pre-eclampsia and effective preventative
treatment strategies.
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